Bausch Health Companies Inc.
BHC· NYSE
Released Oct 30, 2024, after the close
10-Q filed Oct 31, 2024, 31 days after period end · 0000885590-24-000036
| Metric | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2021 |
|---|---|---|---|---|
| Revenue | $2.51B | $2.24B | $2.05B | $2.11B |
| Net Income | -$85.00M | -$378.00M | $399.00M | $188.00M |
| EPS Diluted |
Bausch Health Companies Inc. · CIK 885590 · Engraved from SEC EDGAR
| -$0.23 |
| -$1.03 |
| $1.10 |
| $0.52 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.